Receive up-to-the-minute news updates on the hottest topics with NewsHub. Install now.

Martin Shkreli’s Former Company Loses Race for FDA Approval

September 1, 2017 3:13 PM
7 0

Chemo Group, a rival, won approval for benznidazole, a drug to treat Chagas' disease, in U.S.

Humanigen Inc., a drug-development firm run briefly by convicted fraudster Martin Shkreli, lost out this week in a competition for fast-track regulatory treatment for a drug to treat Chagas' disease, a dangerous parasitic infection.

Chemo Group, not Humanigen, won approval from the U.S. Food and Drug Administration for benznidazole, an established treatment for the disease, in the U.S. Additionally, the FDA granted Chemo Group a...

Source: wsj.com

Share in social networks:

Comments - 0